The Icos Alumni: Where Are They Now?
Luke Timmerman11/18/09Comments (4)Follow @ldtimmerman
(Page 6 of 9)
—Abby Kliphardt, production chemist, Bio-Rad Laboratories
—Joshua Klocke, associate scientist IV, MDS Pharma Services
—Byron Kneller, senior staff scientist, CMC Icos
—Gabrielle Kolakowski, associate scientist, Array Biopharma
—Sandy Kopponol, city council member, city of Lake Forest Park
—Yvonne Lai, professor of biology, Indiana University
—Keith Laycock, network analyst, City of Redmond
—Sam Lee, president, CoCrystal Discovery
—Dina Leviten, scientist, Ikaria
—Michael Libby, assistant director of quality control, Irix Pharmaceuticals
—Marykay Ligocki, research scientist
—Mong-Wu Lin, quality control associate, Dharma Therapeutics
—Brian Lipsky, senior associate research scientist, Amgen
—Mila Lobanova, senior director of finance, ZymoGenetics
—Christine Loh, associate director, Sirtris Pharmaceuticals
—Kate Loughney, medical and scientific writing
—Andrew Lover, graduate student researcher, National University of Singapore
—Mark Lupher, senior vice president of drug discovery, Promedior
—Mack Mabry, senior director, Trubion Pharmaceuticals
—Linda MacKeen, director of medical writing, Seattle Genetics
—Patricia Magnafichi, procurement manager, Genentech
—Benjamin Maier, quality assurance senior specialist, CMC Icos
—Linda Mangone, director of organization development and learning, Regence Blue Cross/BlueShield
—Timothy Martins, co-director Quellos High Throughput Screening Core, Institute for Stem Cell and Regenerative Medicine, University of Washington
—Mari Maurer, director of clinical operations, BioMarin Pharmaceutical [Added 12/30/09]
—Kim Nordstrom McCaw, biotechnology professional
—David McElligott, vice president of research and development, Mirina
—William McFee, scientist, Seattle Genetics
—David Meyer, senior research associate, Seattle Genetics
—Greg Miller, scientist, Bayer Healthcare … Next Page »
Luke Timmerman is the National Biotech Editor of Xconomy, and the Editor of Xconomy Seattle. E-mail him at ltimmerman@xconomy.com or follow him on Twitter at twitter.com/ldtimmerman.
Johnny T. Stine
11/18/09 1:48 pm
I actually loved our logo – very simple, but it just looked like fun.
When George R. was recently asked by a reporter from an Everett newspaper about building Icos into a company like Amgen….he replied “…..why would I stop there?”. With a leader like that, like George, one who inspires with energetic goals such as that mentioned – we could’ve done it. We had the tools and the ability to do just that. We had great people who’ve all proven themselves in places before and afterward…….but imagine what we could’ve done behind the hopes of a great leader like George who set that tone….a CEO who knew all of our names, someone who would talk to you like you were a valued asset, a guy that empowered us via ownership. Imagine what we could’ve done…..because that’s all we’re left to do.
By the way- Luke – I prefer Icosanoids – a play on the word eicosanoid since we were primarily an inflammation company. :-)
Luke Timmerman
11/18/09 2:04 pm
Johnny—Unfortunately, I never really got to know George very well because he had already left Icos by the time I started covering the company in 2001. But I made a point of meeting him at his home once a couple years ago when I was based in San Francisco. He wasn’t in great health, but he was still sharp and very much curious about the latest happenings in biotech.
I haven’t heard the term Icosanoids from eicosanoid, but that made me laugh this morning. It sounds like something from Star Trek. Anybody know if this was also the inspiration for the term “Immunoids” for people who used to work at Immunex?
David Miller
11/23/09 2:54 pm
Nice work, Luke. Goes to prove that even though we might lose companies through acquisition we’d really rather keep, it’s not like everything connected with the company disappears. By my eye, the “loss” of Icos created at least a half-dozen new companies and significantly strengthened a dozen or more startups. A nice silver lining.
Abby Kliphardt
3/3/10 10:19 am
Nice article…good to see where my co-workers have ended. I loved my time at ICOS and will always lament the loss of a great company that was a real family….